Association between regular physical activity and the protective effect of vaccination against SARS-CoV-2 in a South African case-control study.


Journal

British journal of sports medicine
ISSN: 1473-0480
Titre abrégé: Br J Sports Med
Pays: England
ID NLM: 0432520

Informations de publication

Date de publication:
Feb 2023
Historique:
accepted: 19 09 2022
pubmed: 25 10 2022
medline: 7 2 2023
entrez: 24 10 2022
Statut: ppublish

Résumé

Both vaccination and physical activity have been shown to independently decrease the likelihood of severe COVID-19 infection. To assess the association between regular physical activity and vaccination against COVID-19 among healthcare workers. A test negative case-control study design was used to estimate the risk of having an associated COVID-19-related hospital admission, among individuals who were unvaccinated compared with those who were fully vaccinated with Ad26.COV2.S (>28 days after a single dose). 196 444 participant tests were stratified into three measured physical activity subgroups with low, moderate and high activity, to test the hypothesis that physical activity is an effect modifier on the relationship between vaccination and hospitalisation. Vaccine effectiveness against a COVID-19-related admission among vaccinated individuals within the low activity group was 60.0% (95% CI 39.0 to 73.8), 72.1% (95% CI 55.2 to 82.6) for the moderate activity group, and 85.8% (95% CI 74.1 to 92.2) for the high activity group. Compared with individuals with low activity levels, vaccinated individuals with moderate and high activity levels had a 1.4 (95% CI 1.36 to 1.51) and 2.8 (95% CI 2.35 to 3.35) times lower risk of COVID-19 admission, respectively (p value <0.001 for both groups). Regular physical activity was associated with improved vaccine effectiveness against COVID-19 hospitalisation, with higher levels of physical activity associated with greater vaccine effectiveness. Physical activity enhances vaccine effectiveness against severe COVID-19 outcomes and should be encouraged by greater public health messaging.

Sections du résumé

BACKGROUND BACKGROUND
Both vaccination and physical activity have been shown to independently decrease the likelihood of severe COVID-19 infection.
OBJECTIVE OBJECTIVE
To assess the association between regular physical activity and vaccination against COVID-19 among healthcare workers.
METHODS METHODS
A test negative case-control study design was used to estimate the risk of having an associated COVID-19-related hospital admission, among individuals who were unvaccinated compared with those who were fully vaccinated with Ad26.COV2.S (>28 days after a single dose). 196 444 participant tests were stratified into three measured physical activity subgroups with low, moderate and high activity, to test the hypothesis that physical activity is an effect modifier on the relationship between vaccination and hospitalisation.
RESULTS RESULTS
Vaccine effectiveness against a COVID-19-related admission among vaccinated individuals within the low activity group was 60.0% (95% CI 39.0 to 73.8), 72.1% (95% CI 55.2 to 82.6) for the moderate activity group, and 85.8% (95% CI 74.1 to 92.2) for the high activity group. Compared with individuals with low activity levels, vaccinated individuals with moderate and high activity levels had a 1.4 (95% CI 1.36 to 1.51) and 2.8 (95% CI 2.35 to 3.35) times lower risk of COVID-19 admission, respectively (p value <0.001 for both groups).
CONCLUSIONS CONCLUSIONS
Regular physical activity was associated with improved vaccine effectiveness against COVID-19 hospitalisation, with higher levels of physical activity associated with greater vaccine effectiveness. Physical activity enhances vaccine effectiveness against severe COVID-19 outcomes and should be encouraged by greater public health messaging.

Identifiants

pubmed: 36280289
pii: bjsports-2022-105734
doi: 10.1136/bjsports-2022-105734
doi:

Substances chimiques

Ad26COVS1 JT2NS6183B

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

205-211

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: SC, LS and JC are employed by Discovery Health; J P is an editor of BJSM.

Auteurs

Shirley Collie (S)

Healthcare Analytics, Discovery Health, Johannesburg, South Africa.

Robin Terence Saggers (RT)

Wits Sport and Health (WiSH), School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa.
Department of Paediatrics and Child Health, University of the Witwatersrand, Johannesburg, Gauteng, South Africa.

Rossella Bandini (R)

PRINCE: Project to Improve Neonatal Care, School of Clinical Medicine, Faculty of Health Sciences, Wits University, Johannesburg-Braamfontein, Gauteng, South Africa.

Lizelle Steenkamp (L)

Healthcare Analytics, Discovery Health, Johannesburg, South Africa.

Jared Champion (J)

Healthcare Analytics, Discovery Health, Johannesburg, South Africa.

Glenda Gray (G)

COVID-19 Research Committee, South African Medical Research Council, Tygerberg, South Africa.

Linda-Gail Bekker (LG)

Desmond Tutu HIV Centre, University of Cape Town, Observatory, South Africa.

Ameena Goga (A)

COVID-19 Research Committee, South African Medical Research Council, Tygerberg, South Africa.
Department of Paediatrics and Child Health, University of Pretoria, Pretoria, South Africa.

Nigel Garrett (N)

Centre for the Aids Programme of Research in South Africa, Durban, KwaZulu-Natal, South Africa.
School of Nursing and Public Health, Discipline of Public Health Medicine, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.

Jon Patricios (J)

Wits Sport and Health (WiSH), School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa jpat@mweb.co.za.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH